Company intelligence / Profile preview

PharmaCyte Biotech, Inc.

Ownership: Public · PMCB
Employees: ~10
Development stage: Other

Overview

PharmaCyte’s encapsulation technology has shown safety and biocompatibility in preclinical studies. The lead program—targeted chemotherapy for locally advanced pancreatic cancer—has demonstrated effectiveness and minimal side effects in past trials but faces an FDA clinical hold that must be resolved before further advancement. Diabetes and malignant ascites programs are being re-engaged after prior deferral due to resource focus on the lead oncology asset.[7]

Therapeutic areas: OncologyEndocrinology
Modalities: Cell therapy (encapsulated live cell therapy)Gene-modified cells (for insulin production and prodrug activation)[1][2][5]
Industry: Biotech

Drug pipeline

2 assets

Melligen

Preclinical

1 more asset in the full pipeline.

Partnerships

No major pharma partnerships disclosed; recent strategic investments made by PharmaCyte into MyMD Pharmaceuticals ($7M) and Femasys ($5M), indicating business development activity rather than traditional R&D partnerships.[6]

Financials

Market cap: $4M
Total revenue: $0
Enterprise value: $-26.5M

Beyond the preview

Go deeper on PharmaCyte Biotech, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaCyte Biotech, Inc..